Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Gynaecology
  4. Gynaecology guidelines
  5. Back
  6. Guidelines A-Z (all Gynaecology guidelines)
  7. Benign Vulval Skin Conditions (313)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Benign Vulval Skin Conditions (313)

Warning Warning: This guideline is 716 day(s) past its review date.

Please report any inaccuracies or issues with this guideline using our online form

This guideline is to help with initial assessment and care of women with vulval disorders, with advice on when to refer to the specialist multidisciplinary team.

Commonest presentation is with non-specific symptoms such as pruritus, pain and changes in skin colour and texture.

See Appendix 1 for useful questions

This should include the following:

  1. Self medication or previous inadequate or inappropriate treatments which may contribute to symptoms
  2. Cervical cytology, smoking and immune deficiency especially for women with suspected vulval intraepithelial neoplasia (VIN)
  3. Contact with potential allergens or irritants. The most common relevant allergens are cosmetics, medicaments and preservatives. Others include fragrances, rubber, textile dyes, washing powder, fabric conditioners, sanitary towels, panty liners and synthetic underwear. Secondary sensitisation to multiple products is common.
  4. Personal or family history of autoimmune conditions e.g. type 1 diabetes, arthritis, thyroid disease, pernicious anaemia, alopecia, vitiligo
  5. Personal or family history of atopic conditions
  6. History of skin conditions elsewhere on the body – skin and/or mucous membranes
  7. Urinary and/or faecal incontinence. Damage to barrier function or secondary dermatitis exacerbated by moisture, temperature and friction
  8. Impact on sexual function
  9. Drug history to exclude fixed drug eruptions ( e.g. nicorandil )

  1. Perform under a good light, with adequate exposure including peri-anal skin
  2. No necessity for colposcopy or acetic acid, except for examination of VIN
  3. Ask patient to show the affected area first
  4. Consider extra-genital sites: scalp, elbows, knees, nails, oral mucosa
  5. Consider infestations such as scabies, lice, ringworm, pinworm, threadworm
  6. No need to test for auto-immune conditions without a clinical indication
  7. Consider serum ferritin in women with vulval dermatitis. Correction of iron-deficiency anaemia or low serum ferritin can relieve vulval symptoms
  8. STI screen if clinically indicated
  9. Biopsy:
    1. If the woman fails to respond to treatment
    2. There is suspicion of VIN or cancer (20-22% of VIN have invasive cancer on biopsy)
    3. There are atypical or suspicious areas

Benign causes of vulval symptoms include:

Lichen simplex chronicus or Chronic vulval dermatitis: a common inflammatory skin condition, especially in those with sensitive skin, dermatitis or eczema. Severe,intractable pruritis, especially at night. There may be erythema and swelling with discrete areas of thickening and lichenification, especially with scratching. Sometimes linked to stress or low body iron stores.  

Vulval candidiasis: diabetes, obesity and antibiotic use may be contributory. Prolonged topical or oral antifungal therapy may be necessary.

Vulval psoriasis: Involves vulval skin but not vaginal mucosa. The appearance often differs from the typical scale of non-genital sites. It often appears as smooth, non-scaly red or pink discrete lesions.  

Atrophic vulvovaginitis: In premenarchal girls and postmenopausal women. See menopause protocol.

Lichen sclerosus. Skin often pale and affected in a ‘figure-of-eight’ pattern. Inflammation can result in adhesions, fusion and resorption of the labia. See Lichen sclerosus protocol.

Lichen planus: Usually affects mucosal surfaces and commonly seen on oral mucosa. Presents with flat-topped violaceous purpuric plaques and papules with a fine white reticular pattern (Wickham striae) but can be erosive and painful. Erosive LP appears as a well demarcated, glazed erythema around the introitus. Aetiology is unknown, but may be autoimmune. It can affect all ages and not linked to hormonal status. Consider referral to vulval clinic.

Vulval Crohns disease: Vulval involvement by direct extension from involved bowel or metastatic granulomas, rarely preceding or without known bowel disease. Vulva often swollen and oedematous with granulomas, abscesses, ulceration or draining sinuses. Refer to vulval clinic.

Vulvodynia: see vulval pain protocol

General life-style advice is essential in the management of any vulval skin condition. This includes smoking cessation and avoidance of common allergens and irritants (see appendix 2 Vulval skin Care).

The mainstay of treatment for Lichen simplex chronicus is general vulval care and the use of soap substitutes and emollients. Antihistamines or antipruritics may be helpful, especially if sleep is disturbed. Other options include Dermacool or ICL (ichthammol calamine lotion). Moderate or ultrapotent topical steroids may be helpful to break the itch-scratch cycle.

Treatment will depend on the specific diagnosis and should be discussed with a senior clinician.

Women with vulval psoriasis should be followed up in dermatology or vulval clinic.

Clobetasol propionate (eg Dermovate) is the most potent topical steroid available. The ointment preparation is preferred to the cream as it provides better skin contact and is less likely to cause irritation – creams contain propylene glycol, parabens and fragrances. See Appendix 3 for Regime of Steroid Use

Emollients should be prescribed to moisturise, sooth and act as a protective barrier. Women should be advised to leave an interval of at least 30 minutes between emollients and applying other treatments. They can also be stored in the fridge for symptomatic relief. Examples include Dermol 500, Diprobase, Doublebase, Emulsifying ointment, Epaderm, Aqueous cream.

  • Women who have not responded to standard treatment for their vulval condition
  • Women who are requiring frequent prolonged courses of ultra-potent steroids
  • Women whose disease is steroid resistant
  • Women whose symptoms are poorly controlled
  • Women with rare vulval conditions

You have been referred to this clinic with a skin problem. It would be helpful if you could complete this questionnaire before you are seen. This will help to identify any factors that may be causing or aggravating your skin problem. This will be discussed with the doctor, but you may want to add additional notes if you feel it will help you to remember any important information.

YES

NO 

SOMETIMES

Do you take a bath?

Do you take a shower?

Do you wash your hair in the bath or shower?

What do you wash over all with?

What do you wash the vulva area with?

Do you use moist skin wipes in the vulval area?

Do you use talcum powder in the vulval area?

Do you use antiseptic in the bath?

What do you use to wash your clothes?

Do you use a fabric softener/conditioner?

What type/material underwear do you usually wear?

Do you wear dark coloured underwear?

What colour toilet paper do you use?

Do you use tampons?

Do you use sanitary towels?

Do you use panty liners?

Do you use incontinence pads?

Do you use condoms?

The following questions relate to your own health.

Do you have any of the following conditions?

YES

NO

Diabetes

Thyroid disease (over- or underactive thyroid gland)

Alopecia (hair loss)

Pernicious anaemia (treated by monthly vitamin B injections)

Vitiligo (patches of white skin)

Rheumatoid arthritis

Hayfever /asthma

Do you have any allergies?

Do you have any other skin conditions (e.g. eczema, psoriasis, vitiligo, dry skin, sensitive skin, flaky scalp)?

Are you on any medicines? This includes prescribed/ herbal/ over the                counter/ HRT /contraception. 

If you have already tried treatments for your skin problem, please note them below.

Name of treatment

How long did you use it for?

Effects

Genital skin has less of a barrier than other skin surfaces and is more liable to irritation. Many products, even so-called ‘low-allergy’ products can irritate skin. Perfumed products should be avoided. The vulval area only needs washed once a day

Washing

The vulval area only needs washed once a day. Use a small amount of soap substitute as washing with water on its own tends to cause dry skin. Use your hand, avoiding flannels/sponges or over cleaning, as this will irritate. Do not use a vaginal wash as this is unnecessary and may cause irritation.

  • Dry the skin very gently with a soft towel (no rubbing) or use a hairdryer on a cool setting
  • Do not use soaps, bubble-baths, deodorants or vaginal/baby wipes in or around the vulval area and avoid antiseptics in the bath
  • Shower rather than bathe
  • When washing your hair, avoid allowing the shampoo from coming in to contact with the vulval area
  • Soap substitutes include Emulsifying Ointment, E45, Hydromol, Dermol

Clothing

  • Wear loose fitting, non-coloured cotton or silk underwear and change daily. Dark textile days may irritate the skin
  • Sleep without underwear
  • Wash underwear using non-biological washing detergent and avoid fabric conditioner

Irritants

  • Use unscented unbleached tampons, sanitary pads and panty liners. Avoid plastic coated pads
  • If passing urine makes your symptoms worse, wash the urine away from the vulval area using warm water whilst on the toilet (e.g. using a jug or plastic water bottle)
  • If you suffer from urinary incontinence, please ask your GP to prescribe a barrier ointment or spray to protect your skin
  • When swimming or exercising, protect the vulval area with a barrier cream such as emulsifying ointment or hydromol
  • Itching can sometimes be prevented or relieved by just holding the area tightly for several minutes.
  • Avoid wearing nail varnish on finger nails if you tend to scratch.
  • Some over-the-counter products may contain possible irritants e.g. baby/nappy creams, herbal creams and thrush treatments.
  • Aim to use ointments rather than creams as they have less preservatives

Sex

  • If sex is uncomfortable, lubricants such as Sylk (contains kiwi extract) may help
  • Oil based products can cause condoms to break
  • Difficulties with sexual intercourse are common. Please discuss with your doctor

Emollients

These soothe the skin and will rehydrate (moisturise) dry areas. They are usually fragrance-free and less likely to irritate. Used daily they can help relieve symptoms and protect the skin. They can be kept in the fridge and dabbed on to cool and soothe the skin as often as you like.Examples include: Hydromol, Emulsifying Ointment, E45, Dermol, Aveeno, Epaderm

Contacts

The Vulval Pain Society 

Association for Lichen Sclerosus & Vulval Health

Vulval Health Awareness Campaign

Patient Information on the use of Clobetasol Proprionate 0.05% Ointment

You should apply your ointment sparingly (this means half to one finger tip) to the affected area(s).

These are the areas where you have itch/discomfort or notice changes in the skin. Apply the ointment; Once daily for 1 month

Then Alternate (every 2nd) days for 1 month

Then twice a week for 1 month

Then once a week for 1 month

One 30g tube should last at least 3 months. This amount should not cause you to have adverse effects on the treated skin or elsewhere in the body.

If symptoms return after the above course, you can use the ointment every night for 2 weeks to treat the flare-up and then try to reduce the frequency, as above.

If symptoms keep coming back quickly when you stop using the ointment, you may prefer to use it regularly once or twice a week long term. Long term use is safe as long as one 30g tube lasts at least 3 months. More than this may cause skin thinning.

It is normal to notice stinging for a few minutes after applying the ointment. However, if you notice stinging in the area for more than 1-2 hours after applying it, you may have become sensitive to it. There may be alternative ointments and you should contact your GP or the clinic for advice.

Editorial Information

Last reviewed: 18/09/2017

Next review date: 30/04/2023

Author(s): Kay McAllister.

Version: 2

Approved By: Gynaecology Clinical Governance Group

Document Id: 313

References

UK National guideline on the Management of Vulval Conditions. Clinical Effectiveness Group of the British Association of Sexual Health and HIV. Feb 2014 (accessed online April 2017)

Vulval Pain Society 

British Society for the Study of Vulval Disease